Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease.

Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease.
复制标题

DOI:
10.1111/liv.12809
复制
发表时间:
2015-11
期刊:
Liver international : official journal of the International Association for the Study of the Liver
影响因子:
--
通讯作者:
Fan JG
Fan JG
中科院分区:
其他
文献类型:
--
作者:
Shen F;Zheng RD;Shi JP;Mi YQ;Chen GF;Hu X;Liu YG;Wang XY;Pan Q;Chen GY;Chen JN;Xu L;Zhang RN;Xu LM;Fan JG

文献摘要

参考文献

被引文献

相似文献

Controlled attenuation parameter (CAP) is a non‐invasive method for evaluating hepatic steatosis. However, larger skin capsular distance (SCD) can affect the accuracy. The aim of this study was to investigate the impact of SCD on the diagnostic performance of CAP and liver stiffness measurement (LSM). Of 101 patients with non‐alcoholic fatty liver disease (NAFLD) and 280 patients with chronic hepatitis B (CHB) who underwent liver biopsy were prospectively recruited. CAP, LSM and SCD were performed using FibroScan with M probe. The areas under receiver operating characteristics curves (AUROCs) were calculated to determine the diagnostic efficacy. The optimal thresholds were defined by the maximum Youden index. SCD (B 30.34, P < 0.001) and hepatic steatosis (B 23.04, P < 0.001) were independently associated with CAP by multivariate analysis. The AUROCs were slightly higher for SCD <25 mm compared to those for SCD ≥25 mm for steatosis ≥5% (0.88 vs. 0.81), >33% (0.90 vs. 0.85) and >66% (0.84 vs. 0.72). For SCD <25 mm, the optimal CAP cut‐offs for differentiating steatosis ≥5%, >33% and >66% were 255.0 dB/m, 283.5 dB/m and 293.5 dB/m. However, cut‐offs were elevated by approximately 60–70 dB/m for SCD ≥25 mm. When stratified by fibrosis grade, LSM was significantly affected by SCD ≥25 mm for advanced fibrosis (≥F3) in NAFLD, but not in CHB. CAP is a promising tool for detecting and quantifying hepatic steatosis. SCD ≥25 mm may cause overestimation of steatosis. Similarly, SCD ≥25 mm affects the detection of advanced fibrosis by LSM in NAFLD patients.
DOI: 10.1111/j.1365-2893.2011.01534.x
发表时间: 2012-04-01
影响因子: 2.5
作者:
Sasso, M.;Tengher-Barna, I.;Beaugrand, M.
通讯作者: Beaugrand, M.
DOI: 10.1002/hep.24624
发表时间: 2012-01-01
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Myers, Robert P.;Pomier-Layrargues, Gilles;Elkashab, Magdy
通讯作者: Elkashab, Magdy
DOI: 10.1002/hep.510240201
发表时间: 1996-08-01
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Bedossa, P;Poynard, T
通讯作者: Poynard, T
DOI: 10.1111/j.1440-1746.2010.06510.x
发表时间: 2011-02-01
影响因子: 4.1
作者:
Wong, Grace L-H;Wong, Vincent W-S;Chan, Henry L-Y
通讯作者: Chan, Henry L-Y
DOI: 10.1371/journal.pone.0091987
发表时间: 2014
期刊: PloS one
影响因子: 3.7
作者:
Karlas T;Petroff D;Garnov N;Böhm S;Tenckhoff H;Wittekind C;Wiese M;Schiefke I;Linder N;Schaudinn A;Busse H;Kahn T;Mössner J;Berg T;Tröltzsch M;Keim V;Wiegand J
通讯作者: Wiegand J